The government announced a new strategy designed to spur domestic pharmaceutical production, aiming to drastically reduce the country’s heavy reliance on imported medicines and medical supplies.
This initiative, spearheaded by the Ministry of Investments, Trade, and Industry in collaboration with the Ministry of Health and the Kenya Development Corporation (KDC), addresses long-standing economic vulnerabilities and supply chain fragility.